| 释义 |
Neoral
基本例句
内奥拉尔¹⁰⁰
The relative bioavailability of CyA HP50 and CyA HP55 nanoparticles calculated by the AUC 0-72 were 82 3% and 119 6%, bioequivalent to the reference ofNeoral.与Neoral相比 ,CyA HP5 0NP与CyA HP5 5NP的相对生物利用度分别为 82 3%和 1 1 9 6% ,均无显著性差异 ;
Compared with theNeoralmicroemulsion,the relative bioavailability of CyA was 94.8%,115.2%,113.6% and 132.5% for CyA-E100,CyA-L100,CyA-L100-55 and CyA-S100 nanoparticles respectively.与Neoral微乳相比; CyA E100;CyA L100;CyA L100 55和CyA S100纳米粒的相对生物利用度分别为94.;8%;115CyA-S100 nanoparticles was shown to significantly improve the oral bioavailability of CyA compared withNeoralmicroemulsion⎫⎤ |